Less competitive drug makers will likely collapse

Published: 2006-08-28 07:00:00

Updated: 2006-08-28 07:00:00

Pharmaceutical business sources say that from now on, less competitive pharmaceutical firms will not only see their businesses decline but also face shutdowns as well under the currently deteriorating business conditions aggressive assault of leading pharmaceutical firms in clinics, introduction...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK